1. Home
  2. TTEC vs ZNTL Comparison

TTEC vs ZNTL Comparison

Compare TTEC & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTEC
  • ZNTL
  • Stock Information
  • Founded
  • TTEC 1982
  • ZNTL 2014
  • Country
  • TTEC United States
  • ZNTL United States
  • Employees
  • TTEC N/A
  • ZNTL N/A
  • Industry
  • TTEC Retail: Computer Software & Peripheral Equipment
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TTEC Technology
  • ZNTL Health Care
  • Exchange
  • TTEC Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • TTEC 300.1M
  • ZNTL 300.4M
  • IPO Year
  • TTEC 1996
  • ZNTL 2020
  • Fundamental
  • Price
  • TTEC $7.43
  • ZNTL $3.70
  • Analyst Decision
  • TTEC Hold
  • ZNTL Buy
  • Analyst Count
  • TTEC 4
  • ZNTL 7
  • Target Price
  • TTEC $9.67
  • ZNTL $13.14
  • AVG Volume (30 Days)
  • TTEC 834.6K
  • ZNTL 1.6M
  • Earning Date
  • TTEC 08-01-2024
  • ZNTL 08-07-2024
  • Dividend Yield
  • TTEC 7.74%
  • ZNTL N/A
  • EPS Growth
  • TTEC N/A
  • ZNTL N/A
  • EPS
  • TTEC N/A
  • ZNTL N/A
  • Revenue
  • TTEC $2,406,169,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • TTEC N/A
  • ZNTL N/A
  • Revenue Next Year
  • TTEC $3.35
  • ZNTL N/A
  • P/E Ratio
  • TTEC N/A
  • ZNTL N/A
  • Revenue Growth
  • TTEC N/A
  • ZNTL N/A
  • 52 Week Low
  • TTEC $5.01
  • ZNTL $3.27
  • 52 Week High
  • TTEC $34.52
  • ZNTL $29.03
  • Technical
  • Relative Strength Index (RSI)
  • TTEC 61.90
  • ZNTL 30.12
  • Support Level
  • TTEC $5.31
  • ZNTL $3.83
  • Resistance Level
  • TTEC $8.15
  • ZNTL $4.79
  • Average True Range (ATR)
  • TTEC 0.46
  • ZNTL 0.44
  • MACD
  • TTEC 0.24
  • ZNTL 0.26
  • Stochastic Oscillator
  • TTEC 75.09
  • ZNTL 28.29

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and most of the sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: